Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RFL Rafael Holdings Inc
- Stocks
- Healthcare
- NYSE: RFL
Price (delayed)
$1.84
Market cap
$64.57M
P/E Ratio
N/A
Dividend/share
$0.02
EPS
-$0.94
Enterprise value
$27.32M
Rafael Holdings is focused on development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through
Highlights
The debt has plunged by 71% from the previous quarter and by 71% YoY
The EPS has surged by 55% since the previous quarter and by 21% year-on-year
RFL's equity is up by 16% QoQ but it is down by 6% YoY
Rafael Holdings's gross margin has decreased by 11% YoY but it has increased by 11% QoQ
Rafael Holdings's quick ratio has shrunk by 64% YoY and by 62% QoQ
Key stats
What are the main financial stats of RFL
Market
Valuations
Earnings
Shares outstanding
35.09M
Market cap
$64.57M
Enterprise value
$27.32M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.57
Price to sales (P/S)
63.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.32
Revenue
$732,000
Gross profit
$548,000
Operating income
-$20.17M
Net income
-$22.89M
EBIT
-$24.71M
EBITDA
-$24.4M
Free cash flow
-$11.44M
Per share
Balance sheet
Liquidity
EPS
-$0.94
EPS diluted
-$0.94
Free cash flow per share
-$0.45
Book value per share
$3.23
Revenue per share
$0.03
TBVPS
$3.12
Total assets
$108.1M
Total liabilities
$23.58M
Debt
$690,000
Equity
$80.58M
Working capital
$31.41M
Debt to equity
0.01
Current ratio
3.85
Quick ratio
3.48
Net debt/EBITDA
1.53
Margins
Efficiency
Dividend
EBITDA margin
-3,333.5%
Gross margin
74.9%
Net margin
-3,127.6%
Operating margin
-2,754.8%
Return on assets
-24.4%
Return on equity
-30%
Return on invested capital
-46.4%
Return on capital employed
-25.5%
Return on sales
-3,375.3%
Dividend yield
1.03%
DPS
$0.02
Payout ratio
N/A
RFL stock price
How has the Rafael Holdings stock price performed over time
Intraday
-5.64%
1 week
-4.66%
1 month
-2.65%
1 year
26.9%
YTD
11.52%
QTD
6.36%
Financial performance
How have Rafael Holdings's revenue and profit performed over time
Revenue
$732,000
Gross profit
$548,000
Operating income
-$20.17M
Net income
-$22.89M
Gross margin
74.9%
Net margin
-3,127.6%
The operating margin has soared by 85% YoY and by 82% QoQ
The company's operating income has surged by 81% QoQ and by 80% YoY
The net margin has soared by 56% from the previous quarter and by 41% YoY
The net income has soared by 55% since the previous quarter and by 20% year-on-year
Price vs fundamentals
How does RFL's price correlate with its fundamentals
Growth
What is Rafael Holdings's growth rate over time
Valuation
What is Rafael Holdings stock price valuation
P/E
N/A
P/B
0.57
P/S
63.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.32
The EPS has surged by 55% since the previous quarter and by 21% year-on-year
The P/B is 59% lower than the 5-year quarterly average of 1.4 and 5% lower than the last 4 quarters average of 0.6
RFL's equity is up by 16% QoQ but it is down by 6% YoY
The price to sales (P/S) is 61% lower than the 5-year quarterly average of 162.3 but 3.8% higher than the last 4 quarters average of 61.1
The revenue has grown by 36% YoY and by 3.7% from the previous quarter
Efficiency
How efficient is Rafael Holdings business performance
RFL's ROA has soared by 55% QoQ and by 15% YoY
The return on sales has surged by 55% since the previous quarter and by 42% year-on-year
The ROE has soared by 54% from the previous quarter
The ROIC is up by 41% since the previous quarter but it is down by 23% year-on-year
Dividends
What is RFL's dividend history
DPS
$0.02
Dividend yield
1.03%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Rafael Holdings financials performed over time
The total liabilities has soared by 125% QoQ and by 113% YoY
Rafael Holdings's quick ratio has shrunk by 64% YoY and by 62% QoQ
The debt is 99% less than the equity
The debt has plunged by 71% from the previous quarter and by 71% YoY
Rafael Holdings's debt to equity has shrunk by 67% QoQ and by 67% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.